Cargando…

Detection of Liver Lesions in Colorectal Cancer Patients Using (18)F-FDG PET/CT Dual-Time-Point Scan Imaging

SIMPLE SUMMARY: Fluorine-18-fluorodeoxyglucose positron emission computed tomography/computed tomography ((18)F-FDG PET/CT) imaging is crucial for staging, restaging, and therapeutic response assessment in colorectal cancer (CRC) patients. However, (18)F-FDG is not specific for malignant lesions. Du...

Descripción completa

Detalles Bibliográficos
Autores principales: Boanova, Luciane G., Altmayer, Stephan, Watte, Guilherme, Raupp, Ana Amelia, Francisco, Martina Zaguini, De Oliveira, Guilherme Strieder, Hochhegger, Bruno, Andrade, Rubens G. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670707/
https://www.ncbi.nlm.nih.gov/pubmed/38001662
http://dx.doi.org/10.3390/cancers15225403
_version_ 1785149341607919616
author Boanova, Luciane G.
Altmayer, Stephan
Watte, Guilherme
Raupp, Ana Amelia
Francisco, Martina Zaguini
De Oliveira, Guilherme Strieder
Hochhegger, Bruno
Andrade, Rubens G. F.
author_facet Boanova, Luciane G.
Altmayer, Stephan
Watte, Guilherme
Raupp, Ana Amelia
Francisco, Martina Zaguini
De Oliveira, Guilherme Strieder
Hochhegger, Bruno
Andrade, Rubens G. F.
author_sort Boanova, Luciane G.
collection PubMed
description SIMPLE SUMMARY: Fluorine-18-fluorodeoxyglucose positron emission computed tomography/computed tomography ((18)F-FDG PET/CT) imaging is crucial for staging, restaging, and therapeutic response assessment in colorectal cancer (CRC) patients. However, (18)F-FDG is not specific for malignant lesions. Dual-time-point imaging has emerged as a promising tool to address this limitation. Our findings indicate that delayed PET/CT images significantly increased both sensitivity (87.7% vs. 100%) and specificity (94% vs. 91%) compared to standard early images. Therefore, our study demonstrated the added value of dual-time-point scans with little extra cost and radiation exposure. ABSTRACT: Objective: The aim of this study was to evaluate the diagnostic performance of dual-time-point fluorine-18-fluorodeoxyglucose positron emission computed tomography/computed tomography ((18)F-FDG PET/CT) compared to conventional early imaging for detecting colorectal liver metastases (CRLM) in colorectal cancer (CRC) patients. Methods: One hundred twenty-four consecutive CRC patients underwent dual-time-point imaging scans on a retrospective basis. Histopathological confirmation and/or clinical follow-up were accepted as the gold standard. Standard uptake values (SUV), signal-to-noise ratio (SNR), retention index (RI), tumor-to-normal liver ratio (TNR), and lesion sizes were measured for early and delayed PET scans. The diagnostic performance of early and delayed images was calculated on a per-patient basis and compared using McNemar’s test. Results: Among the 124 patients, 57 (46%) had CRLM, 6 (4.8%) had benign lesions, and 61 (49.2%) had no concerning lesions detected. Smaller CRLM lesions (<5 cm(3)) showed significantly higher uptake in the delayed scans relative to early imaging (p < 0.001). The SUV and TNR increased significantly in delayed imaging of all metastatic lesions (p < 0.001). The retention index of all CRLM was high (40.8%), especially for small lesions (54.8%). A total of 177 lesions in delayed images and 124 in standard early images were identified. In a per-patient analysis, delayed imaging had significantly higher sensitivity (100% vs. 87.7%) and specificity (91.0% vs. 94.0%) compared to early imaging (p-value = 0.04). Conclusions: The detection of liver lesions using dual-time-point PET/CT scan improves the sensitivity and specificity for the detection of colorectal liver metastasis.
format Online
Article
Text
id pubmed-10670707
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106707072023-11-14 Detection of Liver Lesions in Colorectal Cancer Patients Using (18)F-FDG PET/CT Dual-Time-Point Scan Imaging Boanova, Luciane G. Altmayer, Stephan Watte, Guilherme Raupp, Ana Amelia Francisco, Martina Zaguini De Oliveira, Guilherme Strieder Hochhegger, Bruno Andrade, Rubens G. F. Cancers (Basel) Article SIMPLE SUMMARY: Fluorine-18-fluorodeoxyglucose positron emission computed tomography/computed tomography ((18)F-FDG PET/CT) imaging is crucial for staging, restaging, and therapeutic response assessment in colorectal cancer (CRC) patients. However, (18)F-FDG is not specific for malignant lesions. Dual-time-point imaging has emerged as a promising tool to address this limitation. Our findings indicate that delayed PET/CT images significantly increased both sensitivity (87.7% vs. 100%) and specificity (94% vs. 91%) compared to standard early images. Therefore, our study demonstrated the added value of dual-time-point scans with little extra cost and radiation exposure. ABSTRACT: Objective: The aim of this study was to evaluate the diagnostic performance of dual-time-point fluorine-18-fluorodeoxyglucose positron emission computed tomography/computed tomography ((18)F-FDG PET/CT) compared to conventional early imaging for detecting colorectal liver metastases (CRLM) in colorectal cancer (CRC) patients. Methods: One hundred twenty-four consecutive CRC patients underwent dual-time-point imaging scans on a retrospective basis. Histopathological confirmation and/or clinical follow-up were accepted as the gold standard. Standard uptake values (SUV), signal-to-noise ratio (SNR), retention index (RI), tumor-to-normal liver ratio (TNR), and lesion sizes were measured for early and delayed PET scans. The diagnostic performance of early and delayed images was calculated on a per-patient basis and compared using McNemar’s test. Results: Among the 124 patients, 57 (46%) had CRLM, 6 (4.8%) had benign lesions, and 61 (49.2%) had no concerning lesions detected. Smaller CRLM lesions (<5 cm(3)) showed significantly higher uptake in the delayed scans relative to early imaging (p < 0.001). The SUV and TNR increased significantly in delayed imaging of all metastatic lesions (p < 0.001). The retention index of all CRLM was high (40.8%), especially for small lesions (54.8%). A total of 177 lesions in delayed images and 124 in standard early images were identified. In a per-patient analysis, delayed imaging had significantly higher sensitivity (100% vs. 87.7%) and specificity (91.0% vs. 94.0%) compared to early imaging (p-value = 0.04). Conclusions: The detection of liver lesions using dual-time-point PET/CT scan improves the sensitivity and specificity for the detection of colorectal liver metastasis. MDPI 2023-11-14 /pmc/articles/PMC10670707/ /pubmed/38001662 http://dx.doi.org/10.3390/cancers15225403 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Boanova, Luciane G.
Altmayer, Stephan
Watte, Guilherme
Raupp, Ana Amelia
Francisco, Martina Zaguini
De Oliveira, Guilherme Strieder
Hochhegger, Bruno
Andrade, Rubens G. F.
Detection of Liver Lesions in Colorectal Cancer Patients Using (18)F-FDG PET/CT Dual-Time-Point Scan Imaging
title Detection of Liver Lesions in Colorectal Cancer Patients Using (18)F-FDG PET/CT Dual-Time-Point Scan Imaging
title_full Detection of Liver Lesions in Colorectal Cancer Patients Using (18)F-FDG PET/CT Dual-Time-Point Scan Imaging
title_fullStr Detection of Liver Lesions in Colorectal Cancer Patients Using (18)F-FDG PET/CT Dual-Time-Point Scan Imaging
title_full_unstemmed Detection of Liver Lesions in Colorectal Cancer Patients Using (18)F-FDG PET/CT Dual-Time-Point Scan Imaging
title_short Detection of Liver Lesions in Colorectal Cancer Patients Using (18)F-FDG PET/CT Dual-Time-Point Scan Imaging
title_sort detection of liver lesions in colorectal cancer patients using (18)f-fdg pet/ct dual-time-point scan imaging
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670707/
https://www.ncbi.nlm.nih.gov/pubmed/38001662
http://dx.doi.org/10.3390/cancers15225403
work_keys_str_mv AT boanovalucianeg detectionofliverlesionsincolorectalcancerpatientsusing18ffdgpetctdualtimepointscanimaging
AT altmayerstephan detectionofliverlesionsincolorectalcancerpatientsusing18ffdgpetctdualtimepointscanimaging
AT watteguilherme detectionofliverlesionsincolorectalcancerpatientsusing18ffdgpetctdualtimepointscanimaging
AT rauppanaamelia detectionofliverlesionsincolorectalcancerpatientsusing18ffdgpetctdualtimepointscanimaging
AT franciscomartinazaguini detectionofliverlesionsincolorectalcancerpatientsusing18ffdgpetctdualtimepointscanimaging
AT deoliveiraguilhermestrieder detectionofliverlesionsincolorectalcancerpatientsusing18ffdgpetctdualtimepointscanimaging
AT hochheggerbruno detectionofliverlesionsincolorectalcancerpatientsusing18ffdgpetctdualtimepointscanimaging
AT andraderubensgf detectionofliverlesionsincolorectalcancerpatientsusing18ffdgpetctdualtimepointscanimaging